F. Kajikawa

Combination effect of recombinant human interleukin 1 alpha with antitumor drugs on syngeneic tumors in mice.

S. Kashimoto, S. Nakamura, K. Nakata, 1991, Cancer research.

Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 1.

K. Hino, S. Kashimoto, Yuji Sato, 2002, Journal of medicinal chemistry.

Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models

U. Hoch, S. Kashimoto, J. Silverman, 2009, Cancer Chemotherapy and Pharmacology.